BioCentury
ARTICLE | Company News

Merz sales and marketing update

November 14, 2011 8:00 AM UTC

Merz launched Xeomin incobotulinumtoxinA in the U.S. as a temporary improvement in the appearance of moderate to severe glabellar lines (frown lines between the eyebrows). Merz already markets Xeomin...